Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.44K Sell
46
-11
-19% -$1.27K ﹤0.01% 649
2026
Q1
$6.81K Buy
57
+1
+2% +$131 ﹤0.01% 529
2025
Q4
$7.63K Buy
56
+9
+19% +$1.29K ﹤0.01% 417
2025
Q3
$6.93K Buy
47
+12
+34% +$1.66K ﹤0.01% 392
2025
Q2
$4.53K Buy
+35
New +$4.24K ﹤0.01% 419

Other funds holding XYL

Kilter Group's XYL Position: Q2 2026 in Review

Kilter Group reduced its Xylem (XYL) stake by 19% in Q2 2026, selling an estimated $1.27K and leaving 46 shares worth $5.44K. The position accounts for ﹤0.01% of the portfolio, ranked #649.

Kilter Group first reported a position in XYL in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.63K in Q4 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Kilter Group held 46 shares of Xylem worth $5.44K as of Q2 2026.
  • Kilter Group sold 11 Xylem shares in Q2 2026, an estimated $1.27K.
  • Xylem made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #649 holding.
  • Kilter Group first reported a position in Xylem in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's Xylem position peaked at $7.63K in Q4 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.